UVA researchers identify a potential treatment for respiratory symptoms of long COVID

Experts from industry and academia and lawmakers reached consensus around the dangers and the drivers of drug shortages but clashed over approaches to solving the

As Am­gen catch­es up with lead­ers in the bur­geon­ing obe­si­ty space, it’s un­der­scor­ing a “plat­form ap­proach” and shoot­ing for “broad op­tion­al­i­ty” in the de­sign of